SCHEMBL20057515

SCHEMBL20057515

CC(=O)NC(=N)C(C)(NC(=O)C1C=CC(C2CC2)=C([S+]([O-])CC(C)C)N1C)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20057359 0.72 CNR2 (0.39) —
SCHEMBL20057373 0.72 CNR2 (0.39) —
SCHEMBL20057514 0.60 CNR2 (0.54) —
SCHEMBL20057357 0.60 CNR2 (0.54) —
SCHEMBL14243479 0.59 CNR2 (0.61) —
SCHEMBL18098815 0.59 CNR2 (0.61) —
SCHEMBL17126913 0.46 EPHX1 (0.41) —
SCHEMBL24882692 0.45 SIGMAR1 (0.33) —
SCHEMBL14037257 0.45 EPHX1 (0.34) —
Lithium SCHEMBL31187692 0.44 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3072886-B1 PYRIDIN-2-AMIDES USEFUL AS CB2 AGONISTS HOFFMANN LA ROCHE (CH) 2018-04-18 — — EP disclosed
Send feedback